The albinism drug market is developing as healthcare systems place greater emphasis on improving diagnosis, treatment, and long-term care for individuals affected by albinism. Growing awareness of the condition and increasing attention to specialized healthcare are supporting opportunities for pharmaceutical and medical technology companies. The albinism drug market size was valued at US$...